Search results
Vasant "Vas" Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis. He succeeded Joseph Jimenez who left Novartis in 2018.
31 de ene. de 2024 · Learn about Vas Narasimhan's biography, achievements and vision as the leader of a global medicines company. He has transformed Novartis with a focus on innovation, culture and access in the last five years.
28. Apr. 2023. Optimism and insights for the work ahead: Four takeaways from the 2023 World Economic Forum. Von Vas Narasimhan. 25. Jan. 2023. Aktivitäten. “Climate change is among the greatest...
Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the company's business operations. ECN members are chosen by the Board of Directors. Download the Novartis organizational structure (PDF 0.2 MB) Chief Executive Officer.
29 de feb. de 2024 · 48 años. 100 relaciones. Health Technology. Consumer Services. Commercial Services. Resumen. Experiencia. Red Personal. Conexiones Empresas. Perfil. Vasant Narasimhan ocupa el cargo de Director General de Novartis AG y Director General de Novartis International AG (filial de Novartis AG).
4 de feb. de 2022 · Vas Narasimhan: the American trying to reshape Novartis. The Swiss company’s chief executive has to decide on the future of its $10bn generics business. Vas Narasimhan, who trained as a...
16 de ene. de 2023 · SAN FRANCISCO — Thousands of layoffs are "happening now" as part of an ongoing restructuring, Vasant Narasimhan, the CEO of Novartis, told Insider, as he hopes the $220 billion Swiss giant is...
